Primer Ventures
Overview
Primer Ventures is a venture capital firm investing in early-stage life science and therapeutic companies. The firm focuses on breakthrough innovations in life science tools and therapeutics, including synthetic biology, genomics, proteomics, single-cell and spatial biology, next-generation analytical equipment, molecular diagnostics, and manufacturing technologies. Primer Ventures aims to empower entrepreneurs to accelerate the development and delivery of disruptive products and therapies to market, supporting the translation of cutting-edge science and technologies into transformative products or therapies.
Investment Focus
- Innovative life science and therapeutic companies at early stages
Portfolio Companies
Reach Primer Ventures directly
Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.
Unlock full contacts →Frequently asked questions about Primer Ventures
What sectors does Primer Ventures invest in?
Primer Ventures invests in Healthcare, Life Sciences, Diagnostics, Biotechnology, Synthetic Biology and Regenerative Medicine, and is based in Palo Alto, United States. Primer Ventures is listed as a venture capital in the ConnectSafely investor database.
What stage does Primer Ventures invest at?
Primer Ventures backs companies at Pre-Seed, Seed, Early Stage, Series A and Series B.
Which regions does Primer Ventures invest in?
Primer Ventures invests across United States.
Who are the partners at Primer Ventures?
Team members listed for Primer Ventures include Lauren Holzer (Founding Partner).
What companies has Primer Ventures invested in?
Primer Ventures's portfolio includes Twist Bioscience and Juno Therapeutics.
How do I contact Primer Ventures?
Primer Ventures's contact details — including LinkedIn — are listed in the ConnectSafely investor database, along with its website and the LinkedIn profiles of its partners.
Last updated · Source: ConnectSafely investor database
